Cited by 28Dementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of LifeAlzheimer's disease research and treatments

Cost-Effectiveness of Dementia Prevention Interventions

Open access
McRae, Ian, Zheng, L., Bourke, S., Cherbuin, N., Anstey, K.J.·2021·The Journal of Prevention of Alzheimer's Disease

Abstract

Background Assessment of cost-effectiveness of interventions to address modifiable risk factors associated with dementia requires estimates of long-term impacts of these interventions which are rarely directly available and must be estimated using a range of assumptions. Objectives To test the cost-effectiveness of dementia prevention measures using a methodology which transparently addresses the many assumptions required to use data from short-term studies, and which readily incorporates sensitivity analyses. Design We explore an approach to estimating cost-effective prices which uses aggregate data including estimated lifetime costs of dementia, both financial and quality of life, and incorporates a range of assumptions regarding sustainability of short- term gains and other parameters. Setting The approach is addressed in the context of the theoretical reduction in a range of risk factors, and in the context of a specific small-scale trial of an internet-based intervention augmented with diet and physical activity consultations. Measurements The principal outcomes were prices per unit of interventions at which interventions were cost-effective or cost-saving. Results Taking a societal perspective, a notional intervention reducing a range of dementia risk-factors by 5% was cost-effective at $A460 per person with higher risk groups at $2,148 per person. The on-line program costing $825 per person was cost-effective at $1,850 per person even if program effect diminished by 75…

Integrity signals

Registry

Crossref · 10.14283/jpad.2020.71

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Research works printed but not linked: 29

  1. Handels, 2019, Challenges and recommendations for the health-economic evaluation of primary prevention programmes for dementia, Aging & mental health, 23, 53, 10.1080/13607863.2017.1390730 · DOI
  2. Kivipelto, 2018, World Wide Fingers will advance dementia prevention, Lancet Neurol, 17, 27, 10.1016/S1474-4422(17)30431-3 · DOI
  3. Nguyen, 2018, Where are we at with model-based economic evaluations of interventions for dementia? a systematic review and quality assessment, International psychogeriatrics, 30, 1593, 10.1017/S1041610218001291 · DOI
  4. Meeuwsen, 2013, Cost-effectiveness of one year dementia follow-up care by memory clinics or general practitioners: economic evaluation of a randomised controlled trial, PloS one., 8, e79797-e, 10.1371/journal.pone.0079797 · DOI
  5. Green, 2019, Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework, Alzheimer's & dementia: the journal of the Alzheimer's Association, 15, 1309, 10.1016/j.jalz.2019.05.004 · DOI
  6. Lin, 2014, Unintended benefits: the potential economic impact of addressing risk factors to prevent Alzheimer's disease, Health affairs (Project Hope), 33, 547, 10.1377/hlthaff.2013.1276 · DOI
  7. Tsiachristas, 2016, B-vitamins are potentially a cost-effective population health strategy to tackle dementia: Too good to be true?, Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2, 156, 10.1016/j.trci.2016.07.002 · DOI
  8. van Baal, 2016, Preventing dementia by promoting physical activity and the long-term impact on health and social care expenditures, Preventive medicine, 85, 78, 10.1016/j.ypmed.2016.01.013 · DOI
  9. Zhang, 2011, Cost-effectiveness of a health intervention program with risk reductions for getting demented: results of a Markov model in a Swedish/Finnish setting, Journal of Alzheimer's disease: JAD, 26, 735, 10.3233/JAD-2011-110065 · DOI
  10. Ashby-Mitchell, 2017, Proportion of dementia in Australia explained by common modifiable risk factors, Alzheimer's Research & Therapy, 9, 11, 10.1186/s13195-017-0238-x · DOI
  11. Anstey, 2020, Internet-based Intervention Augmented with Diet and Physical Activity Consultation to Decrease Risk of Dementia in At-risk Adults in a Primary Care Setting: Pragmatic Randomized Controlled Trial, Journal of Medical Internet Research, 10.2196/19431 · DOI
  12. Wang, 2018, Comparing the ICERs in Medicine Reimbursement Submissions to NICE and PBAC—Does the Presence of an Explicit Threshold Affect the ICER Proposed?, Value in Health, 21, 938, 10.1016/j.jval.2018.01.017 · DOI
  13. Brodaty, 2012, Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia, International psychogeriatrics, 24, 1034, 10.1017/S1041610211002924 · DOI · Paper page
  14. Sachs, 2011, Cognitive impairment: an independent predictor of excess mortality: a cohort study, Annals of internal medicine, 155, 300, 10.7326/0003-4819-155-5-201109060-00007 · DOI
  15. Savva, 2015, Who has undiagnosed dementia? A cross-sectional analysis of participants of the Aging, Demographics and Memory Study, Age and Ageing, 44, 642, 10.1093/ageing/afv020 · DOI
  16. Jutkowitz, 2017, Societal and Family Lifetime Cost of Dementia: Implications for Policy, J Am Geriatr Soc, 65, 2169, 10.1111/jgs.15043 · DOI · Paper page
  17. Gnanamanickam, 2018, Direct health and residential care costs of people living with dementia in Australian residential aged care, International journal of geriatric psychiatry, 33, 859, 10.1002/gps.4842 · DOI
  18. Haaksma, 2020, Survival time tool to guide care planning in people with dementia, Neurology, 94, e538, 10.1212/WNL.0000000000008745 · DOI · Paper page
  19. Strand, 2018, Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway, PloS one, 13, e0204436, 10.1371/journal.pone.0204436 · DOI
  20. Orgeta, 2015, The use of the EQ-5D as a measure of health-related quality of life in people with dementia and their carers, Qual Life Res, 24, 315, 10.1007/s11136-014-0770-0 · DOI
  21. Attema, 2018, Discounting in Economic Evaluations, Pharmacoeconomics, 36, 745, 10.1007/s40273-018-0672-z · DOI
  22. Devlin, 2020, Health today versus health tomorrow: does Australia really care less about its future health than other countries do?, Aust Health Rev, 44, 337, 10.1071/AH20057 · DOI
  23. Plassman, 2011, Incidence of dementia and cognitive impairment, not dementia in the United States, Ann Neurol, 70, 418, 10.1002/ana.22362 · DOI
  24. Brinks, 2013, Age of onset in chronic diseases: new method and application to dementia in Germany, Population Health Metrics, 11, 6, 10.1186/1478-7954-11-6 · DOI
  25. Wolters, 2019, Life Expectancy With and Without Dementia: A Population-Based Study of Dementia Burden and Preventive Potential, Am J Epidemiol, 188, 372, 10.1093/aje/kwy234 · DOI
  26. Anstey, 2014, A self-report risk index to predict occurrence of dementia in three independent cohorts of older adults: the ANU-ADRI, PloS one, 9, e86141, 10.1371/journal.pone.0086141 · DOI
  27. Cherbuin, 2019, Validated Alzheimer's Disease Risk Index (ANU-ADRI) is associated with smaller volumes in the default mode network in the early 60s, Brain imaging and behavior, 13, 65, 10.1007/s11682-017-9789-5 · DOI
  28. Richard, 2012, Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI), Journal of the neurological sciences, 322, 64, 10.1016/j.jns.2012.06.012 · DOI · Paper page
  29. Clare, 2015, The Agewell trial: a pilot randomised controlled trial of a behaviour change intervention to promote healthy ageing and reduce risk of dementia in later life, BMC Psychiatry, 15, 25, 10.1186/s12888-015-0402-4 · DOI

Cited by

Sorted by citations

Authors
McRae, I., Zheng, L., Bourke, S., Cherbuin, N., & Anstey, K. J.
Affiliations
  • Australian National University (AU)
  • UNSW Sydney (AU)
Corresponding author
McRae, Ian
Venue
The Journal of Prevention of Alzheimer's Disease
Publisher
Elsevier BV
Published
2021-04
Volume
8
Issue
2
Pages
210-217
ISSN
2274-5807 (ISSN-L)
OpenAlex
W3116684053
Cited by
28
References
1
Citations by year
2026: 3 · 2025: 9 · 2024: 6 · 2023: 4 · 2022: 5 · 2021: 1
FWCI
2.87
Type
journal article
Language
en
Open access
Locations
  • The Journal of Prevention of Alzheimer s Disease (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • ANU Open Research (Australian National University) (submittedVersion)
  • UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
Funders
  • Dementia Centre for Research Collaboration
  • Medical Research Council
  • National Health and Medical Research Council (1100579, 1102694)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
dementia prevention, cost-effectiveness, modifiable risk factors, online intervention, quality of life, intervention sustainability, sensitivity analysis, societal perspective
MeSH terms
Cost-Benefit Analysis, Delivery of Health Care, Dementia, Humans, Quality of Life, Exercise, Health Care Costs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review